Organization · Micro VC
AmorChem
AmorChem is an early-stage life sciences venture capital fund based in Montreal, Canada, focusing on creating biotech companies from academic research. The fund primarily invests in translational research to bridge the gap between academic innovation and commercial application.
Overview
What AmorChem does
What AmorChem is
AmorChem is an early-stage life sciences venture capital fund based in Montreal, Canada, focusing on creating biotech companies from academic research. The fund primarily invests in translational research to bridge the gap between academic innovation and commercial application.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Micro VC
- Founded
- Founded in 2011
- Approximate age
- About 15 years
- Structured capabilities
- Funder
- Last reviewed
- May 5, 2026
Official channels
Find AmorChem elsewhere
Open the official website or a supported primary organization account.
Capability profile
AmorChem as a funder
Investment thesis
AmorChem focuses on creating biotech companies from academic research, financing translational research to bridge the gap between innovation and commercial application.
Focus narrative
AmorChem invests in translational research necessary to bridge the gap between academic innovation and commercial application in the biotech sector. The fund is particularly focused on supporting university-originated therapeutic or drug-discovery opportunities, primarily within the Quebec and Canadian academic ecosystems.
Value beyond capital
AmorChem adds value to its portfolio companies through scientific diligence, translational research planning, and expertise in drug discovery and development. The firm leverages its deep understanding of the biotech landscape to accelerate the growth of its start-ups.
Focus and fit
- Stages
- Pre-seed · Seed · Friends and Family · Angel · Accelerator
- Regions
- Canada
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 9
- Recorded notable exits
- RNA Zipcode / Kodikaz Therapeutic Solutions
Portfolio context
AmorChem has financed 36 unique innovations and created 9 spin-off companies since its inception. Notable portfolio companies include Inversago Pharma, which develops peripherally restricted CB1 inverse agonists for metabolic diseases; Giiant Pharma, focused on gut-restricted therapeutics for inflammatory bowel disease; and SemaThera, which targets retinopathies through anti-SEMA3A therapies.
Common questions
What to know about AmorChem
Upseed classifies AmorChem under the Micro VC organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
May 5, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.